elliptinium has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiel, JL; De Forges, A; Droz, JP; Ghosn, M; Klink, M; Lupera, H; Piot, G; Rouesse, J; Theodore, C | 1 |
| Amiel, JL; Droz, JP; Ghosn, M; Piot, G; Rouëssé, J; Theodore, C | 1 |
2 other study(ies) available for elliptinium and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Ellipticines; Female; France; Humans; Ifosfamide; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies | 1988 |
Phase II trial with high-dose elliptinium acetate in metastatic renal cell carcinoma.
Topics: Adult; Aged; Alkaloids; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Ellipticines; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1988 |